ArticleAIDS research and therapy2026
Pre-conflict prescription patterns and virological effectiveness of combination antiretroviral therapy (cART) in HIV-1 patients in Tigray, Ethiopia.
Article in AIDS research and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLimited evidence exists on the prescription patterns of combination antiretroviral therapy (cART) and their effectiveness in achieving HIV-1 viral suppression. This study evaluated pre-conflict prescription patterns of cART and their virological effectiveness among HIV-1 patients.
methodsA retrospective, cross-sectional analysis was conducted among 7,689 patients with complete virological and clinical data extracted from the THRI database, covering the pre-war period from July 2018 to October 2020. The data were entered, cleaned, and analyzed using SPSS version 25. Associations between categorical variables and virological outcomes were assessed using Pearson’s χ² test.
resultsAmong 7,689 HIV-1-infected individuals on ART (mean age: 43 ± 13 years; 64.4% female), first-line regimens were predominantly prescribed (91.1%), with strong adherence observed in 73.3% of cases. The most commonly used current regimen was 1 J (53.8%), while initial regimens included 1 C (32.9%), 1E (32.1%), and 1 A (21.6%). Overall, virological suppression was higher among females (4,597, 92.7%) than among males (2,392, 87.5%). Factors significantly associated with viral suppression included female sex, younger age, longer duration on ART, earlier clinical stage, higher CD4 counts, strong adherence, consistent follow-up, and timely regimen switching.
conclusionThis study demonstrates that favorable virological outcomes are strongly associated with patient sex, age, treatment duration, baseline clinical and immunological status, and adherence. The findings underscore the importance of early initiation, individualized regimen optimization, and enhanced support for males and individuals with advanced disease. Strengthening adherence programs, introducing genomic surveillance, and performing in-depth longitudinal studies to evaluate the impact of the war are also timely to further improve treatment outcomes, HIV care revitalization, and curb transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.